1. Home
  2. PCRX vs NPK Comparison

PCRX vs NPK Comparison

Compare PCRX & NPK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PCRX
  • NPK
  • Stock Information
  • Founded
  • PCRX 2006
  • NPK 1905
  • Country
  • PCRX United States
  • NPK United States
  • Employees
  • PCRX N/A
  • NPK N/A
  • Industry
  • PCRX Biotechnology: Pharmaceutical Preparations
  • NPK Ordnance And Accessories
  • Sector
  • PCRX Health Care
  • NPK Industrials
  • Exchange
  • PCRX Nasdaq
  • NPK Nasdaq
  • Market Cap
  • PCRX 604.7M
  • NPK 658.3M
  • IPO Year
  • PCRX 2011
  • NPK N/A
  • Fundamental
  • Price
  • PCRX $18.98
  • NPK $93.27
  • Analyst Decision
  • PCRX Buy
  • NPK
  • Analyst Count
  • PCRX 10
  • NPK 0
  • Target Price
  • PCRX $26.60
  • NPK N/A
  • AVG Volume (30 Days)
  • PCRX 933.0K
  • NPK 53.3K
  • Earning Date
  • PCRX 11-06-2024
  • NPK 11-08-2024
  • Dividend Yield
  • PCRX N/A
  • NPK 1.07%
  • EPS Growth
  • PCRX N/A
  • NPK 43.29
  • EPS
  • PCRX N/A
  • NPK 4.76
  • Revenue
  • PCRX $694,957,000.00
  • NPK $351,952,000.00
  • Revenue This Year
  • PCRX $4.94
  • NPK N/A
  • Revenue Next Year
  • PCRX N/A
  • NPK N/A
  • P/E Ratio
  • PCRX N/A
  • NPK $19.64
  • Revenue Growth
  • PCRX 4.40
  • NPK N/A
  • 52 Week Low
  • PCRX $11.16
  • NPK $69.58
  • 52 Week High
  • PCRX $35.95
  • NPK $93.81
  • Technical
  • Relative Strength Index (RSI)
  • PCRX 54.07
  • NPK 75.25
  • Support Level
  • PCRX $18.73
  • NPK $91.37
  • Resistance Level
  • PCRX $20.34
  • NPK $93.70
  • Average True Range (ATR)
  • PCRX 1.13
  • NPK 1.91
  • MACD
  • PCRX -0.03
  • NPK 0.21
  • Stochastic Oscillator
  • PCRX 64.09
  • NPK 95.66

About PCRX Pacira BioSciences Inc.

Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company has three commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve.

About NPK National Presto Industries Inc.

National Presto Industries Inc has an eclectic product portfolio consisting of household appliances, ammunition, and diapers. The company operates in three segments viz Defense, Housewares/Small Appliance, and Safety. The defense segment which is engaged in manufacturing 40mm ammunition, precision mechanical and electro-mechanical assemblies, and medium caliber cartridge cases; performs Load, Assemble, and Pack (LAP) operations on ordnance-related products for the U.S. Government and prime contractor. While Housewares/Small Appliance segment designs, markets, and distributes housewares and small electrical appliances; the safety segment provides safety technology empowering organizations and individuals to protect what is more important.

Share on Social Networks: